Pleomorphism (cytology)

Pleomorphism is a term used in histology and cytopathology to describe variability in the size, shape and staining of cells and/or their nuclei. Several key determinants of cell and nuclear size, like ploidy and the regulation of cellular metabolism, are commonly disrupted in tumors.^[1] Therefore, cellular and nuclear pleomorphism is one of the earliest hallmarks of cancer progression and a feature characteristic of malignant neoplasms and dysplasia.^[2]^[3] Certain benign cell types may also exhibit pleomorphism, e.g. neuroendocrine cells, Arias-Stella reaction.

A rare type of rhabdomyosarcoma that is found in adults is known as pleomorphic rhabdomyosarcoma.^[4]

Despite the prevalence of pleomorphism in human pathology, its role in disease progression is unclear. In epithelial tissue, pleomorphism in cellular size can induce packing defects and disperse aberrant cells.^[5] But the consequence of atypical cell and nuclear morphology in other tissues is unknown.

References

^ Schmoller, Kurt M.; Skotheim, Jan M. (December 2015). "The Biosynthetic Basis of Cell Size Control". Trends Cell Biol. 25 (12): 793–802. doi:10.1016/j.tcb.2015.10.006. PMC 6773270. PMID 26573465.
^ Travis, W.D.; Brambilla, B.; Burke, A.P; Marx, A.; Nicholson, A.G. (2015). WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: International Agency for Research on Cancer. ISBN 978-92-832-2436-5. Archived from the original on March 21, 2015.
^ El-Naggar, A.K.; Chan, J.C.K.; Grandis, J.R.; Takata, T.; Slootweg, P.J. (23 January 2017). WHO Classification of Head and Neck Tumours. Lyon: International Agency for Research on Cancer. ISBN 978-92-832-2438-9. Archived from the original on 2019-10-31. Retrieved 2019-10-31.
^ Okazaki, Mitsuyoshi; Tajima, Hidehiro; Ohbatake, Yoshinao (21 April 2020). "Pleomorphic rhabdomyosarcoma of the liver in an adult: a rare case report". BMC Surgery. 20 (1): 81. doi:10.1186/s12893-020-00742-7. PMC 7171846. PMID 32316960.
^ Ramanathan, Subramanian P.; Krajnc, Matej; Gibson, Matthew C. (October 2019). "Cell-Size Pleomorphism Drives Aberrant Clone Dispersal in Proliferating Epithelia". Developmental Cell. 51 (1): 49–61.e4. doi:10.1016/j.devcel.2019.08.005. PMC 6903429. PMID 31495693.

This article related to pathology is a stub. You can help Wikipedia by expanding it.

[Schmoller2015-1] Schmoller, Kurt M.; Skotheim, Jan M. (December 2015). "The Biosynthetic Basis of Cell Size Control". Trends Cell Biol. 25 (12): 793–802. doi:10.1016/j.tcb.2015.10.006. PMC 6773270. PMID 26573465.

[Travis2015-2] Travis, W.D.; Brambilla, B.; Burke, A.P; Marx, A.; Nicholson, A.G. (2015). WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: International Agency for Research on Cancer. ISBN 978-92-832-2436-5. Archived from the original on March 21, 2015.

[El-Naggar2017-3] El-Naggar, A.K.; Chan, J.C.K.; Grandis, J.R.; Takata, T.; Slootweg, P.J. (23 January 2017). WHO Classification of Head and Neck Tumours. Lyon: International Agency for Research on Cancer. ISBN 978-92-832-2438-9. Archived from the original on 2019-10-31. Retrieved 2019-10-31.

[BMC2020-4] Okazaki, Mitsuyoshi; Tajima, Hidehiro; Ohbatake, Yoshinao (21 April 2020). "Pleomorphic rhabdomyosarcoma of the liver in an adult: a rare case report". BMC Surgery. 20 (1): 81. doi:10.1186/s12893-020-00742-7. PMC 7171846. PMID 32316960.

[Ramanathan2019-5] Ramanathan, Subramanian P.; Krajnc, Matej; Gibson, Matthew C. (October 2019). "Cell-Size Pleomorphism Drives Aberrant Clone Dispersal in Proliferating Epithelia". Developmental Cell. 51 (1): 49–61.e4. doi:10.1016/j.devcel.2019.08.005. PMC 6903429. PMID 31495693.

[1]

[2]

[3]

[4]

[5]

See also

References